FDA OKs Merck's Dulera for asthma
FDA approved Merck's Dulera, a combination inhaler, for asthma patients 12 years and older, the company announced today.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.